Nachrichten zur Merck KGaA Aktie

Why the Market Dipped But Merck (MRK) Gained Today

Merck (MRK) closed at $79.29 in the latest trading session, marking a +1.29% move from the prior day.…

2 Dividend Stocks to Buy and Never Sell

There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in…

Merck (MRK) Dips More Than Broader Market: What You Should Know

Merck (MRK) concluded the recent trading session at $78.28, signifying a -3.31% move from its prior days close.…

Slowing Gardasil Sales Hurt MRKs Top Line: Is Recovery in the Cards?

Mercks Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Targeted cancer drugs may replace chemo for some patients — and drugmakers say theyre getting closer

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their…

Merck bid to stop Fosamax suit thwarted by Supreme Court

…

Merck trotzt Kennedy

Der Pharmakonzern erhält die wichtige US-Zulassung für ein Vakzin. Der dortige Gesundheitsminister wird derweil seinem Ruf als Impfskeptiker gerecht Der…

2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility

Broader equities have not performed particularly well in 2025. The S&P 500 is barely in the black year to date.…

Heres Why Merck (MRK) Fell More Than Broader Market

In the most recent trading session, Merck (MRK) closed at $80.32, indicating a -1.27% shift from the previous trading day.…

Why Summit Therapeutics Stock Tanked Today

An analysts downbeat new take on Summit Therapeutics (NASDAQ: SMMT) pushed its stock downward on Hump Day. At the end…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Many blue chip stocks pay attractive dividends. The Dow Jones Industrial Average (DJINDICES: ^DJI) is loaded with blue chip stocks.…

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) closed at $81.35 in the latest trading session, marking a +2.55% move from the prior day.…

Merck: Best Case For Option Collars Well Ever See

…

Drug pricing reform talks with US government lack clarity, industry executives say

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how…

Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.…

Will Mercks Keytruda Continue to Drive Growth Amid Looming LOE?

MRK leans on Keytruda for growth as exclusivity loss nears, with new combos and launches aiming to ease reliance.…

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Mercks shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.…

US FDA approves Mercks RSV antibody for infants

The U.S. Food and Drug Administration on Monday approved Mercks preventive antibody shot to protect infants up to one year…

Apple, Warner Bros and Merck rise premarket; Tesla, Robinhood fall By Investing.com

Apple, Warner Bros and Merck rise premarket; Tesla, Robinhood fall…

Mercks cholesterol drug meets main goal in late-stage studies

Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.…

Neue potenzielle Behandlungsstrategie für Hirnmetastasen und leptomeningeale Erkrankung: HER3-DXd zeigt vielversprechende Ergebnisse in der Phase-II-TUXEDO-3-Studie bei Patienten mit begrenzten Therapieoptionen

CHICAGO--(BUSINESS WIRE)--Das führende internationale medizinische Forschungsunternehmen MEDSIR gab heute die positiven Ergebnisse der TUXEDO-3-Studie auf der Jahrestagung 2025 der American…

Merck (MRK) Outpaces Stock Market Gains: What You Should Know

Merck (MRK) concluded the recent trading session at $78.27, signifying a +1.46% move from its prior days close.…

MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout

MoonLake jumps 18% after a report says MRK made a $3 billion-plus offer earlier this year, with talks potentially set…

Merck Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 155 Euro…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 155 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 155 Euro…

MoonLake Immunotherapeutics stock surges on FT report of Merck buyout talks By Investing.com

MoonLake Immunotherapeutics stock surges on FT report of Merck buyout talks…

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on…

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports By Reuters

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports…

3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…

MRKs ADC Drug Combo Shows Antitumor Activity in Lymphoma Study

Merck reports promising response rates for its ADC zilovertamab vedotin in relapsed DLBCL and KRAS inhibitor MK-1084 in solid tumors.…

Merck Buy

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Merck KGaA mit einem Kursziel von 174 Euro auf…

DAX nach Feiertag wieder bei 24.000 – Douglas, Evotec, Fresenius, Merck, Renk und SAP im Check

An Christi Himmelfahrt hat es am deutschen Aktienmarkt bei dünnen Umsätzen etwas an Boden verloren. Die Verluste macht der DAX…

Merck-Aktie unbeeindruckt: Darmstädter Merck will bald Zulassung von Pimicotinib beantragen

Der Technologie- und Pharmakonzern Merck KGaA will nach erfolgreichen klinischen Tests noch in diesem Jahr die Marktzulassung für sein Tumor-Medikament…

Merck plant Zulassungsantrag für Tumor-Medikament

DARMSTADT (dpa-AFX) - Der Technologie- und Pharmakonzern Merck KGaA will nach erfolgreichen klinischen Tests noch in diesem Jahr die…

Merck plant Zulassungsantrag für Tumor-Medikament

DARMSTADT (dpa-AFX) - Der Technologie- und Pharmakonzern Merck KGaA will nach erfolgreichen klinischen Tests noch…

Merck kündigt Antrag für Tumor-Medikament an - Aktie fester

Das teilte das DAX-Unternehmen am Mittwoch vor dem Krebsforscher-Kongress Asco mit, der an diesem Freitag in Chicago beginnt. Merck KGaA…

Merck Proves Why Its Still A Top Pharma Pick

…

Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first…

"If Walmart Is Under Pressure to Raise Prices, Its Going to Have Broader Effects on the Economy."

In this podcast, Motley Fool analyst Tim Beyers and host Ricky Mulvey discuss: Walmarts response to tariff uncertainty. Netflixs booming ad business. How…

ANALYSE-FLASH: Bernstein senkt Ziel für Merck KGaA - Market-Perform

NEW YORK (dpa-AFX) - Das US-Analysehaus Bernstein Research hat das Kursziel für Merck KGaA von 168 auf 147 Euro…

ANALYSE-FLASH: Bernstein senkt Ziel für Merck KGaA - 'Market-Perform'

NEW YORK (dpa-AFX) - Das US-Analysehaus Bernstein Research hat das Kursziel für Merck KGaA von…

MRK Down 21% YTD: Should You Buy, Hold or Sell the Stock?

Merck stock lags industry as Keytruda dependency, Gardasil woes in China, and tariff risks cloud outlook despite pipeline strength and…

3 High-Flying Stocks That Could Soar Even More

Many investors love the "big mo." Thats short for "big momentum." Stocks that are on a roll often keep the…

Bayer, Evonik, Merck investieren Milliarden - aber bleibt die Forschung in Deutschland?

Rekordinvestitionen, doch der Druck steigt: Die deutsche Chemie- und Pharmaindustrie steckt so viele Milliarden in Forschung wie nie zuvor. Doch…

Bayer, Evonik, Merck investieren Milliarden – aber bleibt die Forschung in Deutschland?

Rekordinvestitionen, doch der Druck steigt: Die deutsche Chemie- und Pharmaindustrie steckt so viele Milliarden in Forschung wie nie zuvor. Doch…

Merck investing $895 million in Kansas plant

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in De…

Merck: Undervalued In Light Of Key Risks

…

Merck Aktie nach Prognosesenkung unter Druck!

Schwarzach am Main (www.aktiencheck.de) - Merck Aktie nach Prognosesenkung unter Druck! Der Pharma- und Technologiekonzern Merck (ISIN DE0006599905/ WKN 659990) hat…

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of…